Preventability of Drug-Related Harms - Part I A Systematic Review

被引:46
作者
Ferner, Robin E. [1 ,2 ]
Aronson, Jeffrey K. [3 ]
机构
[1] City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England
[2] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England
[3] Univ Oxford, Dept Primary Hlth Care, Oxford, England
关键词
INAPPROPRIATE MEDICATION USE; EMERGENCY-DEPARTMENT VISITS; ADVERSE EVENTS; POTENTIAL RISKS; HOSPITAL ADMISSIONS; EXPLICIT CRITERIA; ELDERLY-PATIENTS; ERRORS; PREVENTION; SEVERITY;
D O I
10.2165/11538270-000000000-00000
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
'Preventability' is a crucial concept in the literature on adverse drug reactions (ADRs). We have carried out a systematic review in order to identify and analyse the approaches used to define 'preventability' in relation to ADRs. We have restricted this investigation to definitions of preventability and have not dealt with other aspects. We searched MEDLINE (1963-April 2009) and EMBASE (1980-April 2009), without language restriction, for papers in which preventability of ADRs was likely to be defined. We found 234 papers, of which we retrieved 231. Of these, 172 either contained original definitions of preventability or referred to other papers in which preventability was defined. Forty contained no definition, and 19 were not relevant. In the 172 papers selected, we identified eight different general approaches to defining the preventability of ADRs: (1) analysis without explicit criteria; (2) assessment by consensus; (3) preventability linked to error; (4) preventability linked to standards of care; (5) preventability linked to medication-related factors; (6) preventability linked to information technology; (7) categorization of harmful treatments in explicit lists; and (8) a combination of more than one approach.
引用
收藏
页码:985 / 994
页数:10
相关论文
共 68 条
[1]  
[Anonymous], 2001, Drug Ther Bull, V39, P25
[2]   Preventability of Drug-Related Harms - Part II Proposed Criteria, Based on Frameworks that Classify Adverse Drug Reactions [J].
Aronson, Jeffrey K. ;
Ferner, Robin E. .
DRUG SAFETY, 2010, 33 (11) :995-1002
[3]   Medication errors: definitions and classification [J].
Aronson, Jeffrey K. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (06) :599-604
[4]   Clarification of terminology in drug safety [J].
Aronson, JK ;
Ferner, RE .
DRUG SAFETY, 2005, 28 (10) :851-870
[5]  
Baena MI, 2002, Pharm care Esp, V4, P393
[6]   The Canadian Adverse Events Study:: the incidence of adverse events among hospital patients in Canada [J].
Baker, GR ;
Norton, PG ;
Flintoft, V ;
Blais, R ;
Brown, A ;
Cox, J ;
Etchells, E ;
Ghali, WA ;
Hébert, P ;
Majumdar, SR ;
O'Beirne, M ;
Palacios-Derflingher, L ;
Reid, RJ ;
Sheps, S ;
Tamblyn, R .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 170 (11) :1678-1686
[7]  
BAKER GR, E APPENDIX 3 BRIEF D
[8]   POTENTIAL IDENTIFIABILITY AND PREVENTABILITY OF ADVERSE EVENTS USING INFORMATION-SYSTEMS [J].
BATES, DW ;
ONEIL, AC ;
BOYLE, D ;
TEICH, J ;
CHERTOW, GM ;
KOMAROFF, AL ;
BRENNAN, TA .
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 1994, 1 (05) :404-411
[9]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[10]  
BEERS MH, 1991, ARCH INTERN MED, V151, P1825